Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;77(6):e56-e57.
doi: 10.1161/HYPERTENSIONAHA.121.17316. Epub 2021 Mar 25.

Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination

Sylvain Meylan  1 , Françoise Livio  2 , Maryline Foerster  3 , Patrick James Genoud  4 , François Marguet  4 , Gregoire Wuerzner  5 ; CHUV COVID Vaccination Center
Affiliations

Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination

Sylvain Meylan et al. Hypertension. 2021 Jun.
No abstract available

Keywords: headache; humans; hypertension; vaccines; vital signs.

PubMed Disclaimer

Comment in

References

    1. Thompson BG, Brown RD, Jr, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES, Jr, Duckwiler GR, Harris CC, Howard VJ, Johnston SC, et al. ; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention; American Heart Association; American Stroke Association. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2368–2400. doi: 10.1161/STR.0000000000000070 - PubMed
    1. Thomas O, Shipman KE, Day K, Thomas M, Martin U, Dasgupta I. Prevalence and determinants of white coat effect in a large UK hypertension clinic population. J Hum Hypertens. 2016;30:386–391. doi: 10.1038/jhh.2015.95 - PubMed
    1. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine — United States, December 14–23, 2020. Morbidity Mortal Wkly Rep. 2021;70:46–51. doi: 10.15585/mmwr.mm7002e1 - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. ; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577 - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. ; COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416. doi: 10.1056/NEJMoa2035389 - PMC - PubMed

MeSH terms